AMICUS THERAPEUTICS INC (FOLD)
US03152W1099 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -151.58M | -236.57M | -250.46M | -276.85M | -356.39M | |||
| Depreciation Amortization | 7.87M | 5.34M | 6.21M | 8.85M | 4.78M | |||
| Income Taxes - Deferred | -4.94M | 10.00K | 30.00K | -160.00K | -1.42M | |||
| Change In Working Capital | -47.99M | -39.88M | -28.94M | -32.06M | 11.61M | |||
| Interest Paid | 36.09M | 34.36M | 30.47M | 24.68M | 16.97M | |||
| Taxes Paid | 8.53M | 1.61M | 20.03M | 10.37M | N/A | |||
| Other non cash items | 127.55M | 104.52M | 70.66M | 66.94M | 91.00M | |||
| OPERATING CASH FLOW | -69.09M | -166.58M | -202.49M | -233.29M | -250.42M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -7.44M | -3.77M | -3.88M | -3.23M | -20.01M | |||
| Other Investing Activity | 105.50M | 96.08M | 82.65M | -10.35M | 115.17M | |||
| INVESTING CASH FLOW | 98.06M | 92.32M | 78.76M | -13.58M | 95.15M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -20.96M | -280.00K | -480.00K | 230.60M | -420.00K | |||
| Stock Issued/Repurchased | 103.21M | 4.31M | 229.21M | 42.28M | 201.28M | |||
| Other Financing Activity | -20.57M | -11.49M | -16.66M | -10.03M | 16.64M | |||
| FINANCING CASH FLOW | 61.68M | -7.46M | 212.07M | 262.86M | 217.50M | |||
| Exchange Rate Effect | 6.31M | -14.62M | -5.05M | 3.83M | 1.73M | |||
| CHANGE IN CASH | 96.96M | -96.34M | 83.29M | 19.82M | 63.96M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -69.09M | -166.58M | -202.49M | -233.29M | -250.42M | |||
| Capital Expenditure | -7.44M | -3.77M | -3.88M | -3.23M | -20.01M | |||
| FREE CASH FLOW | -76.53M | -170.35M | -206.37M | -236.52M | -270.43M | |||
All data in USD